Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Fibromyalgia: development of symptoms and principles of therapy

https://doi.org/10.14412/2074-2711-2012-357

Full Text:

Abstract

Fibromyalgia is one of the most complex problems of clinical practice. Despite its high prevalence rates in the population and high medical visit rates, fibromyalgia is maldiagnosed. Its clinical symptom development, nosological independence, and the choice of priority treatments are debatable questions. By now the number of randomized trials dealing with the efficiency of treatment for fibromyalgia has substantially increased. This permits the identification of its treatment priorities.

About the Author

Gyuzel Rafkatovna Tabeyeva

Department of Nervous Diseases, Faculty of Therapeutics


References

1. <div><p>Clauw D.J. Fibromyalgia: an overview. Am J Med. 2009;12(Suppl. 1):3-13.</p><p>Gowers W.R. A lecture on lumbago: its lessons and analogues. Br Med J. 1904;1:117-21.</p><p>Müller W. (ed): Generalisierte Tendomyopathie (Fibromyalgie). Darmstadt: Steinkopff Verlag, 1991.</p><p>Smythe H.A., Moldofsky H. Two contributions to understanding of the «fibrositis» syndrome. Bull Rheum Dis 1977;28:928-31.</p><p>Moldofsky H., Scarisbrick P., England R. et al. Musculosceletal symptoms and non-REM sleep disturbance in patients with «fibrositis syndrome» and healthy subjects. Psychosom Med 1975;37:341-51.</p><p>Smythe H.A. «Fibrositis» as a disorder of pain modulation. Clin Rheum Dis. 1979;5:823-32.</p><p>Wolfe F., Smithe H.A., Yunus M.B. et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthr Rheum 1990;33:160-72.</p><p>White K.P., Thompson J. Fibromyalgia syndrome in an Amish community: a controlled study to determine disease and symptom prevalence. J Rheumatol 2003;30:1835-40.</p><p>Wolfe F., Ross K., Anderson J. et al. Aspects of fibromyalgia in general population: sex, pain threshold, and fibromyalgia symptoms. J Rheumatol 1995;22:151-6.</p><p>White K.P., Speechley M., Hart M. et al. The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario. J Rheumatol 1999;26:1570-6.</p><p>Sicras-Mainar A., Rejas J., Navarro R. et al. Treating patients with fibromyalgia in primary care settings under routine medical practice: a claim database cost and burden of illness study. Arthriria Res Ther 2009;11:R54.</p><p>Табеева Г.Р. Фибромиалгия. В кн.: Избранные лекции по неврологии. Под ред. В.Л. Голубева. Эйдос Медиа, 2006;152—70.</p><p>Табеева Г.Р. Болевой синдром у больных фибромиалгией. Рус. мед. журн. 2003;11(10):586-9.</p><p>Ханунов И.Г. Клинико-психологическое, нейрофизиологическое исследование и фототерапия больных фибромиалгией. Автореф. дисс. ... канд. мед. наук. М., 2000;23 с.</p><p>Weir P.T., Harlan G.A., Nkov F.L. The incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cogort study based on International Classification of Diseases, 9th Revision codes. J Clin Rheumatol 2006;12(3):124—8.</p><p>Recla J.M. New and emerging therapeutic agents for the treatment of fibromyalgia: an update. J Pain Res 2010;3:89-103.</p><p>American Pain Society Guidelines for the management of fibromyalgia syndrome pain in adults and children. Available from: http://www.ampainsoc.org/pub/fibromyalgia.ht m. 2005. Accessed Dec 2, 2009.</p><p>Carville S.F., Arendt-Nielsen S., Bliddal H. et al. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis 2008;67(4):536—41.</p><p>Crofford L.J. Pharmaceutical treatment options for fibromyalgia. Curr Rheumatol Rep 2004;6(4):274-80.</p><p>Goldenberg D.L., Burckhardt C., Crofford L. Management of fibromyalgia syndrome. JAMA 2004;292(19):2388—95.</p><p>Hauser W., Bernardy K., Uceyler N. et al. Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis. JAMA 2009;301:198-209.</p><p>Rao S.G., Clauw D.J. The management of fibromyalgia. Drugs Today (Barc) 2004;40(6):539-54.</p><p>Arnold L.M., Russell I.J., Diri E.W. et al. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. J Pain. 2008;9(9):792-805.</p><p>Calandre E.P., Morillas-Arques P., Rodriguez-Lopez C.M. et al. Pregabalin augmentation of quetiapine therapy in the treatment of fibromyalgia: An open-label, prospective trial. Pharmacopsychiatry 2007;40(2):68—71.</p><p>Crofford L.J., Mease P.J., Simpson S.L. et al. Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): A 6-month, double-blind, placebo-controlled trial with pregabalin. Pain 2008;136(3):419—31.</p><p>Crofford L.J., Rowbotham M.C., Mease P.J. et al. Pregabalin for the treatment of fibromyalgia syndrome: Results of a randomized, double-blind, placebo-controlled trial. Arthr Rheum 2005;52(4):1264-73.</p><p>Dworkin R., Sharma U., Stacey B. et al. Long-term treatment of neuropathic pain and fibromyalgia syndrome with pregabalin in treatment-refractory patients. J Pain 2005;6(3):30-30.</p><p>Mease P.J., Russell I.J., Arnold L.M. et al. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. J Rheumatol 2008;35(3):502-14.</p><p>Gajraj N.M. Pregabalin: Its pharmacology and use in pain management. Anesth Analg 2007;105(6):1805—15.</p></div><br />


For citation:


Tabeyeva G.R. Fibromyalgia: development of symptoms and principles of therapy. Neurology, Neuropsychiatry, Psychosomatics. 2012;4(1):23-27. (In Russ.) https://doi.org/10.14412/2074-2711-2012-357

Views: 665


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)